ABSTRACT
Aim: To describe Brazilian web survey methods termed DIABETESvid by assessing the diabetic individuals' self-care practices and their resilience in the COVID-19 pandemic. Method(s): This is a cross-sectional study on data collected from web surveys in the period between 1st September and 19th October 2020, in which socio-demographic, clinical, self-care and resilience variables were investigated. A questionnaire was elaborated and implemented by using the Research Electronic Data Capture platform. Result(s): A total of 1,633 participants were eligible for this study, with a higher frequency of females, 46.5% being aged between 18 and 39 years old, 40.9% being diagnosed with diabetes within 1 to 10 years and all having high level of education. Most of the participants was living in south-eastern Brazil, self-reported type 1 diabetes mellitus and had access to the survey link on WhatsApp. In this 7-week study, it was evidenced that the survey response rate was higher in the first week (38.5%) and number of accesses were increased on Thursdays (20.2%) and in the night (40.2%). Conclusion(s): The method used here can be useful as a baseline for future web surveys involving diabetic individuals so that several analyses can be conducted in the clinical care and academic contexts.Copyright © 2021 The Authors
ABSTRACT
Access to diabetes medications is critical to disease control. However, social distancing in the COVID-19 pandemic may have limited the provision of medicines and supplies. Thus, the objective of this study was to analyze the sources of obtaining diabetes drugs in the COVID-19 pandemic in Brazil. The data came from the DIABETESvid survey, and this analysis considered a convenience sample of 1608 participants who responded to the questionnaire published on social media of scientific societies related to diabetes. This is a cross-sectional study, conducted in the form of a web survey, from September 1 to October 19, 2020. The outcome analyzed was the sources for obtaining diabetes drugs categorized in pharmacies of the "Sistema Único de Saúde", pharmacies of the "Aqui tem Farmácia Popular” program, as well as private pharmacies and drugstores and other sources. Most participants self-reported a diagnosis of type 1 diabetes mellitus (49.8%), used insulin (61.9%), and had a private health plan (68.7%). Private pharmacies and drugstores and other sources were the main places where medicines for diabetes were supplied (47.5%). Participants residing in the Midwest region of the country had a lower frequency of supply in pharmacies in the "Aqui tem Farmácia Popular” program (0.57;95%CI 0.36-0.92). In the studied sample, there was a higher frequency of supply of diabetes drugs in private pharmacies and drugstores and other sources with a reduction in frequency in public pharmacies during the COVID-19 pandemic in Brazil. © 2022 Centro Universitario Sao Camilo. All rights reserved.